论文信息 - HMGCR autoantibody testing: two tiers required. - 字舞流文

HMGCR autoantibody testing: two tiers required.

K. Chow | M. Spellerberg | P. Keating | J. O’Donnell | I. Chua

[1] P. Keating,et al. Response to: New immunoassays for anti-HMG-CoA reductase antibodies may lead to incorrect diagnosis in inflammatory myositis. , 2018, Pathology.

[2] Rufaidah Rushdi,et al. Common Fallacies of Probability in Medical Context: A Simple Mathematical Exposition , 2018 .

[3] D. Cammelli,et al. Bench to bedside review of myositis autoantibodies , 2018, Clinical and Molecular Allergy.

[4] D. Gillis,et al. New immunoassays for anti-HMG-CoA reductase antibodies may lead to incorrect diagnosis in inflammatory myositis. , 2017, Pathology.

[5] M. Labrador-Horrillo,et al. Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories. , 2016, Autoimmunity reviews.

[6] J. O'donnell,et al. HMGCR‐associated myositis: a New Zealand case series and estimate of incidence , 2016, Internal medicine journal.

[7] Richard G. Fowler,et al. Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different Technologies , 2014, Journal of immunology research.

[8] A. Mammen,et al. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. , 2010, Arthritis and rheumatism.

[9] Ferruccio Ceriotti,et al. “Are my Laboratory Results Normal?” Considerations to be Made Concerning Reference Intervals and Decision Limits , 2008, EJIFCC.